Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/17/09 → 3/17/12 |
Funding
- Quintiles, Inc. (S320.2.011)
- Solvay Pharmaceuticals, Inc. (S320.2.011)
Prot# S320.2.011: A Double-Blind, Placebo-Controlled, Randomize, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized with Acute Decompensat
- Courtney, D Mark (PD/PI)
Project: Research project